Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
8.274T
Market Weight
9.32%
Industries
11
Companies
1122
Healthcare S&P 500 ^GSPC
Chart Range Bar
Loading chart for Healthcare

Day Return

Sector
0.90%
S&P 500
0.33%

YTD Return

Sector
14.34%
S&P 500
11.45%

1-Year Return

Sector
30.53%
S&P 500
18.98%

3-Year Return

Sector
33.93%
S&P 500
70.24%

5-Year Return

Sector
20.31%
S&P 500
69.89%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
14.34%
Drug Manufacturers - General
42.33%
28.14%
Biotechnology
14.01%
26.20%
Diagnostics & Research
10.26%
8.57%
Medical Devices
9.63%
-9.05%
Healthcare Plans
8.87%
17.90%
Medical Instruments & Supplies
5.64%
-11.12%
Medical Distribution
2.80%
2.41%
Medical Care Facilities
2.68%
0.81%
Drug Manufacturers - Specialty & Generic
2.26%
-2.43%
Health Information Services
1.51%
-10.89%
Pharmaceutical Retailers
0.00%
-33.53%

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
1,156.73 1,315.04 13.06% 1.031T -1.52% +7.63%
Buy
265.85 272.50 8.11% 640.672B -0.82% +28.46%
Buy
256.42 276.59 5.74% 453.124B +0.37% +12.22%
Buy
147.76 148.73 4.62% 364.549B -0.40% +40.38%
Buy
389.41 475.23 4.43% 349.532B -0.90% +17.96%
Buy
429.88 388.48 2.94% 232.407B -0.59% +31.34%
Buy
617.10 631.42 2.89% 228.171B -0.82% +6.50%
Buy
110.36 120.20 2.43% 192.227B -1.88% -11.92%
Buy
146.34 157.41 2.30% 181.455B +0.45% +19.23%
Buy
28.46 28.61 2.05% 162.213B +1.79% +14.30%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
170.54 41.75B 0.08% +10.17%
319.96 20.899B 0.09% +11.16%
162.50 9.625B 0.35% +33.27%
209.05 9.213B 0.44% +23.87%
104.24 4.093B 0.38% +7.02%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
89.75 38.163B 0.27% +4.06%
212.83 38.163B 0.27% +4.04%
159.99 20.899B 0.09% +11.15%
11.25 16.116B 0.00% +1.23%
135.54 16.116B 0.00% +1.75%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Market Update: HLF, LH, WWW

    The major indices are broadly lower at midday on Monday. There's not much good news out there to celebrate. Renewed strikes between the U.S. and Iran have increased tensions in the Middle East. Oil prices are climbing again. Add to that, Fed Chairman Kevin Warsh hinted last week that rates might be heading higher as inflation stays stubbornly elevated. Crude oil is at $85 per barrel. The yield on the 10-year note is at 4.76%.

     
  • Analyst Report: Labcorp Holdings Inc

    Labcorp operates one of the largest global clinical laboratory networks, providing both routine and specialty testing. It operates in Diagnostics Laboratories and Biopharma Laboratory Services (BLS) segments. BLS supports clinical trial activity for the biopharma industry in approximately 100 countries.

    Rating
    Price Target
     
  • Weekly Stock List

    Earnings season is almost over, with about 97% of S&P 500 companies having reported as of Friday. Many knocked it out of the park, delivering earnings and revenue numbers that were well ahead of expectations. We always look at trends and, as usual, there are companies increasing guidance. Raising guidance is one of our Investing Themes for the second half of 2026. We view management's ability to raise guidance consistently as a catalyst for possible market-beating returns in the quarters ahead. It's even harder for companies to lift guidance during uncertain economic times, as vision is murky. This is true now, as the war in the Middle East drags on. As well, Wall Street has a new chairman of the Federal Reserve, one with a different view about forward-looking guidance (or in this case, a lack thereof). As many companies increased guidance during this earnings cycle, we put out two lists. The first was back on August 3 -- and now we offer up our second list, made up of companies in Argus' fundamental Universe of Coverage. Many of the names in this latest list are in the consumer space, as these companies tend to report at the end of earnings season.

     
  • Technical Assessment: Bullish in the Intermediate-Term

    While this week doesn't have the buildup of last week, there are some key happenings, including Friday's employment report. As well, Technology EPS continue to roll in with PANW, MDB, DELL, and CRDO reporting on Tuesday; AVGO, NTAP, SNOW, and HPE on Wednesday; and CIEN and ZS on Thursday. Software (IGV $109.50), led by cyber security and then cloud computing last week, has outperformed semiconductors (SMH) since late June. IGV gapped to recovery highs on Thursday with strong volume and is closing in on its September 2025 all-time high near $118. SMH remains in a correction as another strong report from Nvidia failed to reignite the former leaders.

     

Healthcare News